Company: NUTR
Filing Date: 2025-03-25
Form Type: CORRESP
Source: 0001641172-25-000449
Chunk: 60

Company: NUSATRIP Inc
Filing Date: 2025-03-25
Form: CORRESP
Chunk 60
---
 the registration statement at the conversion price of $1.50 per share. The Convertible Notes were converted into an aggregate of 1,066,668 shares of Common Stock and issued to the investors, and the three private placements were completed on February 10, 2025.

For the life of warrants and options, the holders
will have the opportunity to profit from a rise in the price of the Common Stock with a resulting dilution in the interest of the other
holders of Common Stock. The existence of such warrants and options may adversely affect the market price of our Common Stock and the
terms on which we can obtain additional financing, and the holders of such warrants and options can be expected to exercise them at a
time when we would, in all likelihood, be able to obtain additional capital by an offering of our unissued capital stock on terms more
favorable to us than those provided by such warrants and options.

Investors in our Common Stock will face immediate and substantial dilution in the net tangible book value per Share and may experience future dilution.

If you purchase shares of our Common Stock in the
IPO, you will pay more for your shares than the net tangible book value of your shares. As a result, you will incur immediate dilution
of $4.0807 per share, representing the difference between the assumed public offering price of $4.5 per share
and our estimated as adjusted net tangible book value as of September 30December 31, 2024 of $0.4243
per share. Accordingly, should we be liquidated at our book value, you would not receive the full amount of your investment. Please refer
to the section titled “Dilution” of this prospectus for more information.

Certain recent initial public offerings of companies with relatively small public floats have experienced extreme volatility that was seemingly unrelated to the underlying performance of the respective company. Our Common Stock may potentially experience rapid and substantial price volatility, which may make it difficult for prospective investors to assess the value of our Common Stock.

In addition to the risks addressed above under “The trading price of our Common Stock will likely be volatile,” our Common Stock may be subject to rapid and substantial price volatility.
We may experience extreme stock price volatility unrelated to our actual or expected operating performance, financial condition or prospects,
making it difficult for prospective investors to assess the rapidly changing value of our Common Stock. Recently, there have been instances
of extreme stock price run-ups followed by rapid price declines and strong stock price volatility with